In 2025, as short videos and digital art continue to thrive, a Chinese AI tool, Kling AI, is reshaping the content creation ...
Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback